Pipeline Leak Detection Market Of The Oil And Gas Industry 2018-2028

Pipeline Leak Detection Market Of The Oil And Gas Industry 2018-2028
LONDON, UK. 1st May 2018: Visiongain’s new 133 page Pipeline Leak Detection Market of the Oil and Gas Industry 2018-2028: Forecasts by Technology (Negative Pressure Wave, E-RTTM, Fibre Optic, Mass/Volume Balance, Vapour Sensing); Location of Application (Onshore and Offshore) Plus Leading Companies, Global, Regional and National Market Analysis indicates that the Pipeline Leak Detection market ...

Global Translational Regenerative Medicine Market Prospects 2018-2028: Stem Cell Therapies, Tissue Engineered Products, Gene Therapies.

Global Translational Regenerative Medicine Market Prospects 2018-2028: Stem Cell Therapies, Tissue Engineered Products, Gene Therapies.
Visiongain’ has launched a new pharma report Global Translational Regenerative Medicine Market Prospects 2018-2028: Stem Cell Therapies, Tissue Engineered Products, Gene Therapies. Regenerative medicine has been undergoing a period of sustained innovation over the last two decades. Tissue engineering and stem cell research in particular have seen a level of interest which it hasn’t received ...

Orphan Drugs Market Report 2018-2028: Forecasts and Analysis By Therapeutic Class , Drug Class & By Region Plus Analysis of Leading Companies

Orphan Drugs Market Report 2018-2028: Forecasts and Analysis By Therapeutic Class , Drug Class  & By Region Plus Analysis of Leading Companies
LONDON, UK. 29th January 2018: Visiongain has launched a new pharma report Orphan Drugs Market Report 2018-2028: Forecasts and Analysis By Therapeutic Class (Oncology, Alimentary Tract & Metabolism, Hormonal Disorders & Haematology, Neuroscience, Respiratory, Cardiovascular, Nephrology and Ophthalmology), Drug Class (Biologic, Small Molecule) & By Region Plus Analysis of Leading Companies An orphan disease is ...

Global Huntington’s Disease Drugs Market Forecast 2018-2028: Forecasts by Drug Class, Leading Companies and Promising Pipeline Molecules

Global Huntington’s Disease Drugs Market Forecast 2018-2028: Forecasts by Drug Class, Leading Companies and Promising Pipeline Molecules
LONDON, UK. 12th January 2018: Visiongain has launched a new pharma report Global Huntington’s Disease Drugs Market Forecast 2018-2028: Forecasts by Drug Class (Antidopaminergics, Antipsychotics, Anticonvulsants, Antidepressants, Other) and Geography, with Analysis for Leading Drugs (Xenazine, Austedo, Clozapine, Haloperidol, Abilify), Leading Companies and Promising Pipeline Molecules   Huntington’s Disease is a progressive neurodegenerative disorder which ...

Latin American Pharmaceutical Market Outlook 2018-2028: Brazil, Mexico, Venezuela, Argentina, Colombia, Chile, Rest of Latin America, Generics, OTC, Biosimilars, Originator Drugs

Latin American Pharmaceutical Market Outlook 2018-2028: Brazil, Mexico, Venezuela, Argentina, Colombia, Chile, Rest of Latin America, Generics, OTC, Biosimilars, Originator Drugs
LONDON, UK. October 2017: Visiongain has launched a new pharma report Latin American Pharmaceutical Market Outlook 2018-2028: Brazil, Mexico, Venezuela, Argentina, Colombia, Chile, Rest of Latin America, Generics, OTC, Biosimilars, Originator Drugs. The Latin American pharmaceutical market accounts for 8% of the global pharmaceutical industry, and is one of its fastest growing markets. Macroeconomic conditions ...

Global Ophthalmic Drugs Market Forecast 2017-2027: Dry Eye, Glaucoma Drugs, Retinal Disorders Drugs and Allergic, Inflammatory & Infective Drugs

Global Ophthalmic Drugs Market Forecast 2017-2027: Dry Eye, Glaucoma Drugs, Retinal Disorders Drugs and Allergic, Inflammatory & Infective Drugs
LONDON, UK June 2017: Visiongain’s new report Global Ophthalmic Drugs Market Forecast 2017-2027: Dry Eye, Glaucoma Drugs, Retinal Disorders Drugs and Allergic, Inflammatory & Infective Drugs indicates that the global ophthalmic drugs market will see $28.1bn in spending in 2021. The global ophthalmic drugs market is expected to grow at a CAGR of 4.0% in ...

Global Next-Generation Antibody Therapies Market Forecast 2017-2027: Antibody-Drug Conjugates, Biosimilar Antibodies, Engineered Antibodies, Bispecific Antibodies, Antibody Fragments and Antibody-Like Proteins

Global Next-Generation Antibody Therapies Market Forecast 2017-2027: Antibody-Drug Conjugates, Biosimilar Antibodies, Engineered Antibodies, Bispecific Antibodies, Antibody Fragments and Antibody-Like Proteins
LONDON, UK May 2017: Visiongain’s new report Global Next-Generation Antibody Therapies Market Forecast 2017-2027: Antibody-Drug Conjugates (ADC), Biosimilar Antibodies, Engineered Antibodies, Bispecific Antibodies, Antibody Fragments and Antibody-Like Proteins (ALPs) indicates that the global next-generation antibody therapies market will see $14.1bn in spending in 2021. The global next-generation antibody therapies market is expected to grow at ...

The Systemic Lupus Erythematosus Market Forecast 2017-2027: Revenue Prospects by Product, Molecule Type, Pharmacological Class and Geography

The Systemic Lupus Erythematosus Market Forecast 2017-2027: Revenue Prospects by Product, Molecule Type, Pharmacological Class and Geography
LONDON, UK. 8th May 2017: Visiongain’s new report The Systemic Lupus Erythematosus (SLE) Market Forecast 2017-2027: Revenue Prospects by Product, Molecule Type (Small Molecules, mAbs, Recombinant Proteins), Pharmacological Class (B-Cell Targeting, Interferon Receptor Antagonists, CD Antagonists, Other) and Geography indicates that the SLE market will see over $570m in revenue in 2017. The lead analyst ...

Global Translational Regenerative Medicine Market Prospects 2017-2027: Stem Cell Therapies, Tissue Engineered Products, Gene Therapies

Global Translational Regenerative Medicine Market Prospects 2017-2027: Stem Cell Therapies, Tissue Engineered Products, Gene Therapies
Translational Regenerative Medicine (TRM) refers to the efforts to ‘translate’ preclinical research on regenerative medicine into clinical therapies – “from bench to bedside”. A great deal of basic research has been performed in the past few decades investigating the therapeutic potential of stem cells, gene replacement and bioengineered tissues. We are now at a point ...

Asthma & COPD Market Report 2016-2026: Forecasts for Bronchodilator Monotherapy (Including Anticholinergics, SABAs and LABAs), Anti-Inflammatory Drugs (Including Corticosteroids, Anti-Leukotrienes and Monoclonal Antibodies) and Combination Drugs

Asthma & COPD Market Report 2016-2026:  Forecasts for Bronchodilator Monotherapy (Including Anticholinergics, SABAs and LABAs), Anti-Inflammatory Drugs (Including Corticosteroids, Anti-Leukotrienes and Monoclonal Antibodies) and Combination Drugs
Asthma & COPD market definition Asthma is a common, chronic lung disease in which a combination of inflammation of the small airways of the lung, airway obstruction and bronchial hyper-responsiveness leads to impaired respiratory function and the classic asthma symptoms of coughing, wheezing, shortness of breath and chest tightness. Chronic obstructive pulmonary disease (COPD), sometimes ...